News | Radiation Therapy | January 15, 2016

Society applauds initiative announced in State of the Union address

January 15, 2016 — The American Society for Radiation Oncology (ASTRO) applauded President Obama and Vice President Biden for the “moonshot” effort in cancer research announced in the President’s State of the Union speech on Tuesday.

ASTRO pledged its support of the initiative to bolster resources and foster collaboration among the oncology research community, as well as Vice President Biden’s call in October 2015 to “end cancer as we know it today.”

Despite a two-decade span of decline in cancer death rates, the disease remains a leading source of morbidity and mortality for Americans. The American Cancer Society estimates that nearly 1.7 million Americans will receive cancer diagnoses in 2016, including one in three women and one in two men.

More than half of cancer patients undergo radiation therapy at some point in their treatment, either alone or in conjunction with other treatment options. Existing research demonstrates the effectiveness of radiation therapy as well as its potential in combination with other treatments. ASTRO supports the President’s request to bolster research initiatives that encompass the full range of multidisciplinary therapies in the quest to eradicate cancer.

ASTRO supports research, education and professional training to improve care and outcomes for cancer patients. In 2015 alone, the society provided scientists nearly $1 million through grants and awards supporting radiation oncology research. ASTRO also publishes three medical journals and hosts a variety of scientific meetings in an effort to advance cancer science and help the field avoid the “silos” cautioned in Vice President Biden’s statement, ultimately with the goal of improving patient lives.

For more information: www.astro.org


Related Content

News | Artificial Intelligence

March 28, 2024 — As artificial intelligence (AI) makes its way into cancer care – and into discussions between ...

Time March 28, 2024
arrow
News | Prostate Cancer

March 27, 2024 — A minimally invasive treatment using MRI and transurethral ultrasound instead of surgery or radiation ...

Time March 27, 2024
arrow
Videos | Radiation Oncology

In the conclusion of this 3-part video series on recent advancements in diagnostic radiology, current editorial advisory ...

Time March 19, 2024
arrow
News | Breast Imaging

March 18, 2024 — QT Imaging Holdings, Inc., a medical device company engaged in research, development, and ...

Time March 18, 2024
arrow
Feature | Radiation Oncology | By Christine Book

Appreciating the considerable advances in the clinical application of artificial intelligence (AI) within healthcare ...

Time March 06, 2024
arrow
News | FDA

March 1, 2024 — Varian, a Siemens Healthineers company, announced that it has received 510(k) clearance from the U.S ...

Time March 01, 2024
arrow
News | Breast Imaging

February 22, 2024 — The FAST-Forward randomized trial from the UK found that ultrahypofractionated whole breast ...

Time February 22, 2024
arrow
News | Radiation Oncology

February 22, 2024 — The National Institutes of Health has launched a clinical trials network to evaluate emerging ...

Time February 22, 2024
arrow
News | Radiation Oncology

February 14, 2024 — Accuray Incorporated announced that the team at Quebec’s Montérégie Integrated Cancer Center, part ...

Time February 14, 2024
arrow
News | Radiation Oncology

February 12, 2024 — Radformation, a global pioneer in radiation oncology software solutions, is pleased to announce its ...

Time February 12, 2024
arrow
Subscribe Now